PROTOCOL
VascuNet™ Pericyte Co-Culture Assay
VascuNet™Pericyte共培养试验
Vasculogenesis and angiogenesis are the mechanisms responsible for the development of a vascular network. Both endothelial cells and pericytes are key cell types in these processes. While endothelial cells form the lining of the vessels, pericytes are essential to the development of functional vasculature by stabilizing established vessel structures and facilitating local remodeling for network expansion. In addition to conveying structural support, pericytes are also integral in directing endothelial cells via cell-to-cell contact and paracrine signaling. Pericytes have been shown to co-localize with endothelial cells in both normal and abnormal vasculature, and have been implicated in playing a central role in numerous pathologies, including tumorigenesis, neurodegenerative disorders, and diabetic retinopathy.
血管生成和血管生成是血管网络发育的机制。内皮细胞和周细胞都是这些过程中的关键细胞类型。而内皮 细胞是血管的内层,周细胞通过稳定已建立的血管结构和促进网络e的局部重塑,对功能血管的发展至关重要。 xpansion。除了传递结构支持外,周细胞还通过细胞与细胞的接触和旁分泌信号来引导内皮细胞。周细胞已被证明为共室细胞。 在正常和异常血管系统中,内皮细胞与血管内皮细胞结合,并参与多种病理学中的中心作用,包括肿瘤发生、神经退行性疾病。 糖尿病视网膜病变。
The VascuNet Pericyte Co-Culture Assay combines human embryonic stem cell (ESI-017)-derived pericytes (PC-M cells) with primary human umbilical vein endothelial cells (HUVECs) in a co-culture system designed for a 96-well plate format. These unique PC-M cells display several key properties of pericytes, including expression of CD146, pro-angiogenic function, and effective stabilization of endothelial tube networks. The HUVECs and PC-M cell co- culture system supports vasculogenic tube assembly, resulting in the generation of extensive tube networks that persists at least 4 to 6 days in culture. Vasculogenic tube networks formed with the VascuNet Pericyte Co-Culture Assay persist over 4 times longer in culture than those formed by other assay systems, allowing researchers to study the relevant timing of delivery and long-term efficacy of pro- and anti-angiogenic compounds.
人胚胎干细胞(esi-017)衍生周细胞(pc-M细胞)与原代人脐静脉内皮细胞(HUVECs)在共培养系统中的结合。 设计的96井板格式。这些*的pc-M细胞显示了周细胞的几个关键特性,包括CD 146的表达、促血管生成功能以及内皮细胞的有效稳定。 光管网络。HUVECs和pc-M细胞共培养系统支持血管生成管的组装,从而产生了在Cultur至少持续4至6天的广泛的管状网络。 e.用VascuNet Pericyte共培养法形成的致血管网络在培养过程中的持续时间是其他检测系统的4倍以上,这使得研究人员可以研究该方法。 促血管生成化合物和抗血管生成化合物的时间安排和长期疗效。
REQUIRED MATERIALS所需材料
The VascuNet Pericyte Co-Culture Assay kit contains PC-M cells, HUVECs, and all media components for cell expansion and vasculogenic assay. Each kit undergoes extensive quality control to ensure reproducible vasculogenic tube assembly.
Vascune-周细胞共培养检测试剂盒含有PC-M细胞、HUVECs和所有用于细胞扩增和血管生成测定的培养基成分。每个套件都进行了全面的质量控制,以确保RPR。 可排卵的血管生成管组装。
Kit Component | Quantity | Storage Condition |
Cells: | ||
PC-M cells (ESI-017-derived pericytes) p19 | 1 vial ≥ 5.0 × 105 cells/vial | Liquid Nitrogen |
HUVECs (secondary donor pool) p5 | 1 vial ≥ 1.0 × 106 cells/vial | Liquid Nitrogen |
VascuNet Growth Medium Components: | ||
VascuNet Basal Medium | 475 mL | 2 to 8°C |
Recombinant Human VEGF | 0.5 mL | -20°C |
Recombinant Human EGF | 0.5 mL | -20°C |
Recombinant Human IGF-1 | 0.5 mL | -20°C |
Recombinant Human FGF basic | 0.5 mL | -20°C |
Ascorbic Acid | 0.5 mL | -20°C |
Heparin Sulfate | 0.5 mL | -20°C |
Hydrocotrisone Hemisuccinate | 0.5 mL | -20°C |
FBS | 25 mL | -20°C |
L-Glutamine | 25 mL | -20°C |
VascuNet Assay Medium Components: | ||
VascuNet Basal Assay Medium | 95 mL | 2 to 8°C |
L-Glutamine | 5 mL | -20°C |
Negative Control: | ||
Suramin Hexasodium Salt | 0.5 mL, 1 mM in H2O | -20°C |
Ensure that kit components are stored at the indicated temperatures upon kit arrival. The VascuNet Pericyte Co- Culture Assay components are stable for a minimum of 3 months from date of receipt when stored as directed.
确保组件在组件到达时以的温度存储。VascuNet Pericyte共同培养测试组件从收到时起至少3个月内是稳定的。 按指示存储。
附加所需试剂和材料
96孔组织培养板
Experimental Timeline
Assay Set-up
实验时间线
Row 1: Control Row
H: HUVEC Monoculture Reference (40,000 cells/well)
P: PC-M Monoculture Reference (2,000 cells/well)
C: Co-Cultures (20:1 ratio of HUVEC:PC-M; 40,000 HUVECs and 2,000 PC-M cells/well)
Blue: HUVEC & PC-M Cell Co-Culture (Positive Control)
Yellow: HUVEC & PC-M Cell Co-Culture with 50 µM Suramin Hexasodium Salt (Negative Control)
第1行:控制行
h:HUVEC单一培养参考资料(40,000个细胞/井)
P:PC-M单细胞培养参比(2,000个细胞/井)
C:共培养(20:1的HUVEC:PC-M;40,000 HUVECs和2,000个PC-M细胞/井)
蓝:HUVEC&PC-M细胞共培养(阳性对照)
黄:HUVEC&PC-M细胞与50 M苏拉明六钠盐共培养(阴性对照
Figure 1. Example assay set-up in a 96-well plate. The first row of the VascuNet Pericyte Co-Culture Assay is a control row, containing triplicate samples of monoculture wells and positive and negative control co-culture wells. The remaining 84 wells of the plate may be used for test compounds. Test compound assays may be performed following the same mono- and co-culture set-up as the control row, or simply as co-culture wells.
图1.在一个96井的平板上进行测试。VascunetPericyte共培养试验的行是对照行,包含三份单一培养井的样本以及阳性和阴性的样本。 控制共培养井。该板的其余84口井可用作试验化合物。测试复合测试可以按照与控制行相同的单文化和共培养设置执行。 或者简单地说是共文化水井。
EXPANSION OF HUVECs AND PC-M CELLS
HUVECs和PC-M细胞的扩增
The HUVECs and PC-M cells must be thawed and expanded individually for two days before they can be plated for the experimental set-up in a co-culture format.
Monitor cell proliferation, and do not allow either the HUVECs or PC-M cells to proliferate to more than 90% confluency during expansion. At high confluency dense cell clusters may form, which can decrease vasculogenic tube assembly in mono- and co-cultures.
HUVECs和PC-M细胞必须单独解冻和扩张两天,然后才能以共同培养的形式进行实验设置。
监测细胞增殖,不允许HUVECs或PC-M细胞在扩张过程中增殖至90%以上。在高汇合度时,可形成密集的细胞团簇。 单培养和共培养时血管生成管的组装。
Prepare VascuNet Growth Medium for HUVECs and PC-M Cell Expansion
rhVEGF, rhEGF, rhIGF-1, rhFGF basic, Ascorbic Acid, Heparin Sulfate, Hydrocortosone Hemisuccinate, FBS, L-Glutamine
HUVECs和PC-M细胞扩增用VascuNet生长培养基的制备
将以下VascuNet生长介质从-20℃储存中移除,并允许下列试剂在2至8℃解冻:
rhVEGF,rhEGF,rhIGF-1,rhFGF碱性,抗坏血酸,硫酸肝素,半琥珀酸氢皮质酮,FBS,L-谷氨酰胺
VascuNet Basal Medium 475 mL
rhVEGF 0.5 mL
rhEGF 0.5 mL
rhIGF-1 0.5 mL
rhFGF basic 0.5 mL
Ascorbic Acid 0.5 mL
Heparin Sulfate 0.5 mL Hydrocotrisone Hemisuccinate 0.5 mL FBS 25 mL
通过结合下面列出的所有试剂,准备VascuNet生长培养基。
VascuNet Basal培养基475 mL
rhVEGF 0.5 mL
rhEGF 0.5 mL
rhIGF-1 0.5 mL
rhFGF碱性0.5 mL
抗坏血酸0.5mL
硫酸肝素0.5 mL氢曲松半琥珀酸0.5 mL FBS 25 mL
L-谷氨酰胺25 mL
吸出上清液,在10 mL的VascuNet培养基中轻轻悬浮细胞颗粒。
Thaw and Plate PC-M Cells for Expansion 用于膨胀的解冻板PC-M电池
Note: The PC-M cells are plated at a higher density than the HUVECs.注:PC-M细胞的密度高于HUVECs.
37°C条件下,5%CO2加湿培养细胞
Once the HUVECs and PC-M cells have been expanded, the HUVEC and PC-M cells are plated in co-cultures and monoculture wells of a 96-well plate for the angiogenesis assay. Experimental and control assay wells are established to determine the effects of test compounds on angiogenesis.一旦HUVECs和PC-M细胞被扩增,HUVEC和PC-M细胞被镀在96孔板的共培养和单培养井中进行血管生成实验。试验与控制驴 我们建立了测试井,以确定试验化合物对血管生成的影响。
Prepare 96-well Assay Plate制备96井试井板
Note: Thaw a sufficient amount of GFR Matrigel to coat the total amount of wells used for the experiment, including the control row (see Fig. 1). Each well used in the assay will require 50 µL of Matrigel solution.注:融化足够数量的GFR Matrigel,以覆盖总数量的井用于实验,包括控制排(见图1)。在分析中使用的每一口井都需要50升的MAT。 Rigel溶液
Note: The GFR Matrigel will solidify rapidly when warmed above 2 to 8°C. To ensure even coating and distribution of the matrix, keep all of the reagents, tips, and plate on ice.注:GFR Matrigel在温度高于2°~8°C时会迅速凝固,以保证基体的均匀涂层和分布,使所有试剂、针尖和平板保持在冰上。
VascuNet Basal Assay Medium 95 mL VascuNet Basal试验培养基95 mL
L-Glutamine 5 mL L-谷氨酰胺5mL
将剩余的VascuNet检测介质保存在2至8°C处,多2周。
Note: It is essential to thoroughly resuspend the cells to single-cell suspension before plating for the angiogenic assay.注:在进行血管生成试验前,必须将细胞*重新悬浮到单细胞悬浮液中。
Note: It is essential to thoroughly resuspend the cells to single-cell suspension before plating for the angiogenic assay.注:在进行血管生成试验前,必须将细胞*重新悬浮到单细胞悬浮液中。
在VascuNet检测培养基中稀释PC-M细胞,浓度为1x105个活细胞/mL。
Refer to sample plate set-up diagram (Fig. 1). In addition to the experimental wells, one row of the 96-well plate will be utilized for control wells. Determine the total number of cells needed, in addition to the control row, based on the number of test samples.参考样板设置图(图1).除试验井外,96口井板中的一行井将用于控制井。确定所需单元格的总数,在 到控制行,根据测试样本的数量。
Note: This will make a 20:1 ratio of HUVEC:PC-M cells.注:这将使HUVEC:PC-M细胞的比例达到20:1.
Following the 4 to 6 hour incubation period, visualy inspect the wells to confirm attachment and tube formation in both HUVEC monocultures and co-culture conditions (see Fig. 2). After confirmation of initial tube formation,
the cells are ready to be treated with the test reagents. For best results, this is done 4 to 6 hours after plating, but must be completed within 24 hours after cells are plated.在4到6小时的潜伏期后,目视检查水井,以确定在HUVEC单细胞培养和共培养条件下的附着和管状形成(见图2)。确认后 初的管状,这些细胞已准备好用试验试剂处理。为了取得良好的效果,这是在电镀后4至6小时,但必须在24小时内完成电池被镀。
Figure 2. VascuNet HUVEC and PC-M Cell Co-Culture at 4 hours. Co-Culture of HUVEC and PC-M cells seeded at a 20:1 ratio begin formation of tube networks as early as 4 hours.
图2.VascuNet HUVEC和PC-M细胞共培养4小时.人脐静脉内皮细胞(HUVEC)与PC-M细胞按20:1比例共培养,4小时开始形成管状网络。
Positive control wells contain cells in co-culture at a 20:1 (HUVEC:PC-M cell) ratio in VascuNet Assay Medium. No additional compounds are added to these wells.阳性对照井在VascuNet检测培养基中含有20:1(HUVEC:PC-M细胞)比例的细胞。在这些井中不添加任何额外的化合物。
The negative control samples are run in triplicate co-culture conditions with 50 µM Suramin Hexasodium Salt.阴性对照样品一式三份,共培养条件为50 m苏拉明六钠盐。
Experimental wells should be tested in co-culture wells in triplicates. Triplicate monoculture samples can also be run for comparison.实验威尔斯应在共培养威尔斯中试验三次。三份的单一栽培样品也可用于比较。
Note: Vascular tube formations in co-cultures containing both HUVECs and PC-M cells will be stable for at least 4 days in culture without the need to replace media or add exogenous factors.每4至24小时观察和成像细胞,以监测血管生成管的组装和稳定性。
注:在含有HUVECs和PC-M细胞的共培养中,血管管状细胞在培养中至少稳定4天,不需要更换培养基或添加外源因子。
The following data describes the expected results for co-culture and monoculture conditions at the recommended cell seeding density of 42,000 cells per well containing a 20:1 ratio of HUVECs to PC-M cells (40,000 HUVECs and 2,000 PC-M cells).以下数据描述了在建议的细胞播种密度为每井42,000个细胞时,共培养和单一培养条件下的预期结果,其中含有20:1的HUVECs与pc-m的比例。 细胞(40,000 HUVECs和2,000个PC-M细胞).
Figure 3. Stability of tube structures over time. HUVEC monocultures (rows 1 and 2) seeded at 120,000 cells/cm2 and stained with Vybrant DiO (green), show tube formation on Day 1 post seeding. By day 2, degredation of the vessels is already observed. In contrast, tube structures with multiple branching points are visible from Day 1 and are still stable at Day 6 in the HUVEC and PC-M cell co-cultured wells plated at a 20:1 ratio (rows 3 and 4). PC-M cells are stained red with Vybrant Dil.
Images were taken at 4X magnification.
图3.随着时间的推移,管状结构的稳定性。HUVEC单眼(第1行和第2行)在12万个细胞/cm2下播种,用VybrantDio(绿色)染色,在播种后第1天出现管状形成。白天 2、已观察到船舶的高度。相比之下,具有多个分支点的管状结构从第1天就可以看到,在HUVEC和pc-M细胞共培养中,在第6天仍保持稳定。 红色水井按20:1比例镀制(第3和第4行)。PC-M细胞用Vybrant Dil染红。
图像以4X放大倍数拍摄。
APPENDIX
Reagent | Source | Catalog Number |
VascuNet Pericyte Co-Culture Assay | ESI BIO | EM-2202 |
Corning® Matrigel® Growth Factor Reduced (GFR) Basement Membrane Matrix, *LDEV-Free |
Corning |
354230 |
Accutase® Cell Detachment Solution | Innovative Cell Technologies | AT104 – 100 mL |
REFERENCES
Armulik, A., et al. (2005) Endothelial/pericyte interactions. Circ Res 97: 512–523.
Benjamin, L.E., et al. (1998) A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591–1598.
Bergers, G., et al. (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111: 1287–1295.
Blocki, A., et al. (2013) Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. Stem Cells Dev 22: 2347–2355.
Gerhardt, H., and Betsholtz, C. (2003) Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 314: 15–23.
Hamilton, N.B., et al. (2010) Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and disease. Front Neuroenergetics 2: 5.
Stratman, A.N., et al. (2009) Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 114: 5091–5101.
von Tell, D., et al. (2006) Pericytes and vascular stability. Exp Cell Res 312: 623–629.
Zimmerlin, L., et al. (2010) Stromal vascular progenitors in adult human adipose tissue. Cytometry A 77A: 22–30.
参考( reference的名词复数 )
阿穆利克,A,等。(2005)内皮细胞/周细胞相互作用。CIRC RES 97:512—523。
本杰明,L.E.,等人。(1998)血管重塑的可塑性窗口是由预先形成的内皮网络的周细胞覆盖来定义的,由PDGF-B和VEGF调节。发展125 : 1591–1598.
Bergers,G.等人.(2003)用激酶抑制剂靶向肿瘤血管中的周细胞和内皮细胞的好处。j克莱因投资111:1287-1295。
Blocki,A.,等人。(2013)并非所有骨髓间充质干细胞都能作为周细胞:体外功能试验来区分周细胞和其他间充质干细胞在血管生成方面的作用。干细胞研发22:2347-2355。
Gerhardt,H.和Betsholtz,C.(2003)内皮-周细胞在血管生成中的相互作用。细胞组织研究314:15-23。
汉密尔顿,N.B.,等。(2010)围生体介导的毛细血管直径调节:健康和疾病中神经的血管耦合的一个组成部分。前神经能量学2:5。
施特拉曼,A.N.,等。(2009)血管生成管组装过程中围生细胞的招募刺激内皮基底膜基质的形成。血液114:5091-5101。
冯泰尔,D.(2006)周细胞和血管稳定性。实验细胞RES 312:623-629。
Zimulin,L,等。(2010)成人脂肪组织间质血管祖细胞。细胞计数A 77:22 - 30。
Matrigel is a registered trademark of Corning, Inc.
Accutase is a trademark of Innovative Cell Technologies, Inc.
© ESI BIO 2015. Unless otherwise noted, ESI BIO, ESI BIO logo and all other trademarks are the property of BioTime, Inc
ESI BIO产品目录:
货号 | 品名 | 规格 | 品牌 |
GS310 | HyStem® Hydrogel Kit | 2.5 mL | ESIBIO |
GS311 | HyStem® Hydrogel Kit | 7.5 mL | ESIBIO |
GS1004 | HyStem® Hydrogel Kit | 12.5 mL | ESIBIO |
GS310P | HyStem® Hydrogel Kit w/ PEGSSDA | 2.5 mL | ESIBIO |
GS311P | HyStem® Hydrogel Kit w/ PEGSSDA | 7.5 mL | ESIBIO |
GS312 | HyStem®-C Hydrogel Kit | 2.5 mL | ESIBIO |
GS313 | HyStem®-C Hydrogel Kit | 7.5 mL | ESIBIO |
GS1005 | HyStem®-C Hydrogel Kit | 12.5 mL | ESIBIO |
GS312P | HyStem®-C Hydrogel Kit w/ PEGSSDA | 2.5 mL | ESIBIO |
GS313P | HyStem®-C Hydrogel Kit w/ PEGSSDA | 7.5 mL | ESIBIO |
GS314 | HyStem®-HP Hydrogel Kit | 2.5 mL | ESIBIO |
GS315 | HyStem®-HP Hydrogel Kit | 7.5 mL | ESIBIO |
GS1006 | HyStem®-HP Hydrogel Kit | 12.5 mL | ESIBIO |
GS314P | HyStem®-HP Hydrogel Kit w/ PEGSSDA | 2.5 mL | ESIBIO |
GS315P | HyStem®-HP Hydrogel Kit w/ PEGSSDA | 7.5 mL | ESIBIO |
GS1007 | HyStem® Hydrogel UV QuickSet Kit | 2.5 mL | ESIBIO |
GS1008 | HyStem® Hydrogel UV QuickSet Kit | 7.5 mL | ESIBIO |
GS450 | PEGgel Kit | 1 mL | ESIBIO |
GS240 | DG Water | 10 mL | ESIBIO |
GS241 | DG Water | 20 mL | ESIBIO |
GS3007 | Extralink® Vial | 0.5 mL | ESIBIO |
GS3006 | Extralink® Vial | 2.5 mL | ESIBIO |
GS3009 | Extralink® Lite Vial | 0.5 mL | ESIBIO |
GS3008 | Extralink® Lite Vial | 2.5 mL | ESIBIO |
5050 | Fibronectin | 1 mg | ESIBIO |
GS231 | Gelin-S® Thiol-modified Gelatin | 1 mL | ESIBIO |
GS230 | Gelin-S® Thiol-modified Gelatin | 5 mL | ESIBIO |
GS222 | Glycosil® Hyaluronic Acid | 1 mL | ESIBIO |
GS220 | Glycosil® Hyaluronic Acid | 5 mL | ESIBIO |
GS217 | Heprasil® Hyaluronic Acid | 1 mL | ESIBIO |
GS215 | Heprasil® Hyaluronic Acid | 5 mL | ESIBIO |
5010-D | Nutragen® Bovine Collagen | 50 mL | ESIBIO |
GS711 | PEGDA | 1 mL | ESIBIO |
GS700 | PEGDA | 1 g | ESIBIO |
GS705 | PEGDA | 5 g | ESIBIO |
GS755 | PEGSSDA | 0.5 mL | ESIBIO |
5020 | PEPTITE-2000® RGD Peptide | 5 mg | ESIBIO |
5005-B | PureCol® Collagen | 100 mL | ESIBIO |
5007-A | VitroCol® Collagen | 20 mL | ESIBIO |
5051 | Vitronectin | 0.1 mg | ESIBIO |
EM2203 | ExoSense™ CD63 Exosome ELISA Kit | 96 assays | ESIBIO |
EM2202 | VascuNet™ CoCulture Assay Kit | 1 Kit | ESIBIO |
ST11006 | BioLiteTM SSEA-1 (DyLight 488) anti-Human/Mouse Antibody | 100 µL | ESIBIO |
ST11008 | BioLiteTM TRA-1-81 (DyLight 488) anti-Human Antibody | 100 µL | ESIBIO |
ST11023 | Nestin anti-Human Antibody | 100 µL | ESIBIO |
ST11003 | Oct4 anti-Human/Mouse Antibody | 100 µL | ESIBIO |
ST11001 | Sox2 anti-Human/Mouse Antibody | 100 µL | ESIBIO |
ST11013 | SSEA-1 anti-Human/Mouse Antibody | 100 µL | ESIBIO |
ST11014 | SSEA-3 anti-Human/Mouse Antibody | 100 µL | ESIBIO |
ST11015 | SSEA-4 anti-Human Antibody | 100 µL | ESIBIO |
ST11018 | TRA-1-60 (PE) anti-Human Antibody | 100 µL | ESIBIO |
ST11016 | TRA-1-60 anti-Human Antibody | 100 µL | ESIBIO |
ST11017 | TRA-1-81 anti-Human Antibody | 100 µL | ESIBIO |
ST12007 | LIF, Mouse Recombinant | 10 µg | ESIBIO |
ST12008 | LIF, Mouse Recombinant | 100 µg | ESIBIO |
ES-84 | PureStem® 4D20.8, NCr-fac Progenitor | ea | ESIBIO |
ES-98 | PureStem® E15, Meso-prx/latp Progenitor | ea | ESIBIO |
ES-283 | PureStem® 7PEND24, NCr-fac Progenitor | ea | ESIBIO |
ES-278 | PureStem® 7SMOO32, NCr-fac Progenitor | ea | ESIBIO |
ES-250 | PureStem® SK11, NCr-fac Progenitor | ea | ESIBIO |
ES-268 | PureStem® MEL2, NCr-fac Progenitor | ea | ESIBIO |
ES-256 | PureStem® SM30, NCr-fac Progenitor | ea | ESIBIO |
ES-335 | PureStem® ES-335 Meso-latp Progenitor | ea | ESIBIO |
ES-100 | PureStem® E72 BETATROPHIN+ Progenitor | ea | ESIBIO |
ES-1001 | PureStem® ES-1001 GDF11+ Progenitor | ea | ESIBIO |
ES-184 | PureStem® EN7 Progenitor | ea | ESIBIO |
ES-101 | PureStem® ES-101 Progenitor | ea | ESIBIO |
ES-139 | PureStem® ES-139 Progenitor | ea | ESIBIO |
ES-154 | PureStem® ES-154 Progenitor | ea | ESIBIO |
ES-198 | PureStem® ES-198 Progenitor | ea | ESIBIO |
ES-199 | PureStem® ES-199 Progenitor | ea | ESIBIO |
ES-209 | PureStem® ES-209, Meso-prx/latp Progenitor | ea | ESIBIO |
ES-210 | PureStem® ES-210, Ecto-ntu Progenitor | ea | ESIBIO |
ES-236 | PureStem® ES-236 Progenitor | ea | ESIBIO |
ES-170 | PureStem® E44 Progenitor | ea | ESIBIO |
ES-196 | PureStem® W10 Progenitor | ea | ESIBIO |
ES-194 | PureStem® Z11, Meso Progenitor | ea | ESIBIO |
EM-1001 | PureStem® Progenitor Growth Media, EPM k01 | 500 mL | ESIBIO |
EM-1002 | PureStem® Progenitor Growth Media, EPM k02 | 500 mL | ESIBIO |
EM-1003 | PureStem® Progenitor Growth Media, EPM k03 | 500 mL | ESIBIO |
EM-1004 | PureStem® Progenitor Growth Media, EPM k04 | 500 mL | ESIBIO |
EM-1005 | PureStem® Progenitor Growth Media, EPM k05 | 500 mL | ESIBIO |
EM-1006 | PureStem® Progenitor Growth Media, EPM k06 | 500 mL | ESIBIO |
EM-1007 | PureStem® Progenitor Growth Media, EPM k07 | 500 mL | ESIBIO |
EM-1008 | PureStem® Progenitor Growth Media, EPM k08 | 500 mL | ESIBIO |
EM-2002 | HyStem®-4D Chondrogenesis Differentiation Kit | 1 Kit | ESIBIO |
EM-2007 | HyStem®-4D Differentiation Kit | 1 Kit | ESIBIO |
EM-2001 | PureStem® Chondrogenesis Differentiation Kit | 1 Kit | ESIBIO |
EM-2006 | PureStem® Choroid Plexus Differentiation Kit | 1 Kit | ESIBIO |
EM-2003 | PureStem® Osteogenesis Differentiation Kit 01 | 1 Kit | ESIBIO |
EM-2004 | PureStem® Osteogenesis Differentiation Kit 02 | 1 Kit | ESIBIO |
ST10035 | LY411575 | 5 mg | ESIBIO |
ST10008 | PD0325901 | 2 mg | ESIBIO |
ST10009 | PD0325901 | 10 mg | ESIBIO |
ST10010 | PD0325901 | 415 µL, 10 mM | ESIBIO |
ST10034 | PD173074 | 2 mg | ESIBIO |
ST10021 | RepSox | 5 mg | ESIBIO |
ST10027 | RG108 | 5 mg | ESIBIO |
ST10024 | SB203580 | 2 mg | ESIBIO |
ST10012 | SB431542 | 5 mg | ESIBIO |
ST10013 | SB431542 | 10 mg | ESIBIO |
ST10014 | SB431542 | 1.3 mL, 10 mM | ESIBIO |
ST10025 | SP600125 | 5 mg | ESIBIO |
ST10015 | Thiazovivin | 2 mg | ESIBIO |
ST10017 | XAV939 | 2 mg | ESIBIO |
ST10018 | Y27632 | 2 mg | ESIBIO |
ST10019 | Y27632 | 10 mg | ESIBIO |
ST10020 | Y27632 | 625 µL, 10 mM | ESIBIO |
新奥门原料免费资料是实验试剂一站式采购服务商
1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。
2:产品种类齐全,经营超过700多品牌,基本涵盖所有生物实验试剂耗材。
3:提供加急服务,货品一般1-2周到货。
4:富有竞争力的价格优势,绝大部分价格有优势。
5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等知药企。
6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司授权代理。
7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知*批发,欢迎合作。